Dec 24, 2025 · Repare Therapeutics is a clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to developing novel medicines.

Check out the drug pipeline for Repare Therapeutics, a clinical-stage precision oncology company discovering and developing synthetic lethal therapies.

Repare Therapeutics is a leading clinical-stage precision oncology company enabled by synthetic lethality approach to the discovery and development of novel therapeutics. Repare Therapeutics has …

Repare Therapeutics is a leading clinical-stage precision oncology company enabled by our proprietary synthetic lethality approach to discovering and developing novel therapeutics. We developed highly …

Learn about the therapeutic focus for Repare Therapeutics, a clinical-stage precision oncology company developing novel, synthetic lethal medicines.

Learn about scientifc discovery platorm at Repare Therapeutics, a clinical-stage precision oncology company developing novel, synthetic lethal medicines.

Learn about the team at Repare Therapeutics, a clinical-stage precision oncology company discovering and developing novel, synthetic lethal medicines.

Dec 24, 2025 · Repare Therapeutics has developed highly targeted cancer therapies focused on genomic instability, including DNA damage repair. For more information, please visit …

Jan 16, 2026 · Press releases for Repare Therapeutics, a clinical-stage precision oncology company discovering and developing novel, synthetic lethal medicines.

CAMBRIDGE, Mass. & MONTREAL -- (BUSINESS WIRE)--Nov. 14, 2025-- Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a clinical-stage precision oncology company, today …